Johns Hopkins Center for Psychedelic and Consciousness Research is the world's largest center dedicated to the scientific exploration of psychedelics and their potential role in treating various mental health disorders, enhancing well-being, and expanding our understanding of consciousness. The center was established following the pioneering work of Dr. Roland Griffiths, who, in 2000, obtained regulatory approval to restart research on psychedelics in the United States. This marked the end of a decades-long hiatus triggered by unfavorable media attention and strict regulations in the 1970s. The center's groundbreaking research, which has been published in over 150 peer-reviewed scientific journals, makes Johns Hopkins a global leader in psychedelic studies. Their studies cover a range of challenging conditions, including addiction, existential distress caused by life-threatening diseases, major depressive disorder, anorexia nervosa, Post-Treatment Lyme Disease, depression associated with Alzheimer's Disease, and Obsessive-Compulsive Disorder. The research also extends to healthy volunteers, providing unique insights into the lasting positive effects of psilocybin and its neurophysiological mechanisms. At its core, the Johns Hopkins Center for Psychedelic and Consciousness Research aims to answer key questions in psychedelic therapy and research, and broaden the field of psychedelic science in collaboration with the best multi-disciplinary scientists in the world. The center is committed to conducting rigorous clinical trials that adhere to the highest ethical standards, understanding the mechanics underlying psychedelic effects and therapeutic efficacy, and providing evidence-based education to clinicians and the broader community. The center is proactive in communicating its findings and progress, offering email updates on the latest news and upcoming studies. It also features a range of articles on its website to further educate and inform about their research. The center's work has been recognized and featured in several reputable publications, including The New York Times, Time Magazine, and National Geographic, underlining its prominence and influence in the field of psychedelic research.